GLP-1 injections recalled nationwide over sterility concerns

· foxbusiness.com

Apothecary Pharma is recalling compounded GLP-1 and NAD+ injections nationwide over sterility concerns. The FDA previously warned the company about production practices.

Apothecary Pharma is recalling 23 vials of injectable drugs distributed nationwide because their sterility cannot be assured, according to the Food and Drug Adm...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI